Effect of niacin ER/lovastatin on claudication symptoms in patients with peripheral artery disease (Q43138170)

14 November 2017

title

Effect of niacin ER/lovastatin on claudication symptoms in patients with peripheral artery disease (English)

1 reference

14 November 2017

1 reference

1 reference

Christie M. Ballantyne

6

object named as

Christie M Ballantyne

1 reference

14 November 2017

Judith G. Regensteiner

7

object named as

Judith G Regensteiner

1 reference

14 November 2017

1

William R Hiatt

1 reference

14 November 2017

Alan T Hirsch

2

1 reference

14 November 2017

Mark A Creager

3

1 reference

14 November 2017

Sanjay Rajagopalan

4

1 reference

14 November 2017

Emile R Mohler

5

1 reference

14 November 2017

Diane Treat-Jacobson

8

1 reference

14 November 2017

Rita A Dale

9

1 reference

14 November 2017

Thom Rooke

10

1 reference

14 November 2017

publication date

8 March 2010

1 reference

14 November 2017

1 reference

14 November 2017

volume

15

1 reference

14 November 2017

issue

3

1 reference

14 November 2017

page(s)

171-179

1 reference

ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society f

14 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1358863X09360579

Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X09360579

Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X09360579

Long-term safety of cilostazol in patients with peripheral artery disease: the CASTLE study (Cilostazol: A Study in Long-term Effects).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X09360579

Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X09360579

Effects of simvastatin on walking performance and symptoms of intermittent claudication in hypercholesterolemic patients with peripheral vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X09360579

Effect of simvastatin versus placebo on treadmill exercise time until the onset of intermittent claudication in older patients with peripheral arterial disease at six months and at one year after treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X09360579

Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X09360579

The effects of extended-release niacin on carotid intimal media thickness, endothelial function and inflammatory markers in patients with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X09360579

Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with sta

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X09360579

Effects of colestipol-niacin therapy on human femoral atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X09360579

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X09360579

Statin myotoxicity is associated with changes in the cardiopulmonary function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X09360579

Effects of simvastatin and atorvastatin administration on insulin resistance and respiratory quotient in aged dyslipidemic non-insulin dependent diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X09360579

Elevated ICAM-1 and MCP-1 plasma levels in subjects at high cardiovascular risk are diminished by atorvastatin treatment. Atorvastatin on Inflammatory Markers study: a substudy of Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titrati

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X09360579

Improvement in endothelium dysfunction in diabetics treated with statins: a randomized comparison of atorvastatin 20 mg versus rosuvastatin 10 mg.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X09360579

Atorvastatin restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X09360579

Nicotinic acid, alone and in combinations, for reduction of cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X09360579

Mechanism of action of niacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X09360579

Niacin inhibits vascular oxidative stress, redox-sensitive genes, and monocyte adhesion to human aortic endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X09360579

Effects of oral niacin on endothelial dysfunction in patients with coronary artery disease: results of the randomized, double-blind, placebo-controlled INEF study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X09360579

Effects of prolonged intensive lipid-lowering therapy on the characteristics of carotid atherosclerotic plaques in vivo by MRI: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X09360579

Niacin plus Simvastatin Reduces Coronary Stenosis Progression Among Patients with Metabolic Syndrome Despite a Modest Increase in Insulin Resistance: A Subgroup Analysis of the HDL-Atherosclerosis Treatment Study (HATS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X09360579

Effects of niacin on glucose control in patients with dyslipidemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X09360579

21 January 2018

Identifiers

DOI

10.1177/1358863X09360579

1 reference

14 November 2017

1 reference